WILLIAM HUANG

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TRAVIS AFB, CA NPI 1821177569

General Payments — all program years on this page

$1,858.00

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 73
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $455.83 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $455.8319

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $285.304
2019 $123.821
2022 $374.6620
2023 $618.3929
2024 $455.8319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1085805247 SpringWorks Therapeutics, Inc. $25.55 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091956835 Ipsen Biopharmaceuticals, Inc $14.97 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101113316 Celgene Corporation $22.75 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101113332 Celgene Corporation $23.13 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101113334 Celgene Corporation $32.93 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103948570 ABBVIE INC. $34.22 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104310040 AstraZeneca Pharmaceuticals LP $21.65 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105523803 AstraZeneca Pharmaceuticals LP $19.72 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105702354 AstraZeneca Pharmaceuticals LP $28.14 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105803203 AstraZeneca Pharmaceuticals LP $23.30 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131661268 ARRAY BIOPHARMA INC $23.08 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141750113 Merck Sharp & Dohme LLC $26.89 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141750281 Merck Sharp & Dohme LLC $29.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141750283 Merck Sharp & Dohme LLC $29.29 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144959326 Takeda Pharmaceuticals U.S.A., Inc. $17.57 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144959328 Takeda Pharmaceuticals U.S.A., Inc. $22.74 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145873555 Deciphera Pharmaceuticals Inc. $14.45 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148180990 PolyNovo North America LLC $14.65 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150233942 JAZZ PHARMACEUTICALS INC. $31.12 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.